Serum levels of the CC chemokines CCL2, CCL5, and CCL11 in food allergic children with different clinical manifestations

Inflammation

Volumn 36, Issue 3, 2013, Pages 561-566

  Radman, Masood ^a   Hassanshahi, Gholamhossin ^a   Vazirinejad, Reza ^a   Arababadi, Mohammad Kazemi ^a   Karimabad, Mojgan Noorozi ^a   Khorramdelazad, Hossein ^a   Rafatpanah, Houshang ^b   Iranmanesh, Fereshteh ^a   Hakimizadeh, Elham ^a   Ahmadi, Zahra ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CC chemokine; CCL11; CCL2; CCL5; food allergy

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN E; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ALLERGIC ASTHMA; ANAPHYLAXIS; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EOSINOPHIL COUNT; EOTAXIN BLOOD LEVEL; FEMALE; FOOD ALLERGY; FOOD INTAKE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN E BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILK ALLERGY; MONOCYTE CHEMOTACTIC PROTEIN 1 BLOOD LEVEL; PISTACHIO; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; RANTES BLOOD LEVEL; URTICARIA;

ANAPHYLAXIS; ASTHMA; CHEMOKINE CCL11; CHEMOKINE CCL2; CHEMOKINE CCL5; CHILD; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MALE; URTICARIA;

PISTACIA VERA;

EID: 84877730641     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9577-8     Document Type: Article

References (34)

1. Greener, M. 2000. Dissecting the molecular basis of food allergy. Molecular Medicine Today 6(9): 336.
2. Kim, J.W., et al. 2009. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochemical Pharmacology 77(9): 1506-1512. Epub 2009 Feb 6.
3. Bischoff, S.C., et al. 1996. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28(1): 1-13.
4. Bischoff, S.C., and S. Kramer. 2007. Human mast cells, bacteria, and intestinal immunity. Immunology Reviews 217: 329-337.
5. Bischoff, S.C. 2009. Physiological and pathophysiological functions of intestinal mast cells. Seminars in Immunopathology 31(2): 185-205. Epub 2009 Jun 17.
6. Frew, A.J. 1996. The immunology of respiratory allergies. Toxicology Letters 86(2-3): 65-72.
7. Piliponsky, A.M., et al. 2003. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101(5): 1898-1904. Epub 2002 Oct 10.
8. Drazen, J.M., J.P. Arm, and K.F. Austen. 1996. Sorting out the cytokines of asthma. The Journal of Experimental Medicine 183(1): 1-5.
9. Broide, D., and P. Sriramarao. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunology Reviews 179: 163-172.
10. Aminzadeh, F., et al. 2012. Differential expression of CXC chemokines CXCL10 and CXCL12 in term and pre-term neonates and their mothers. American Journal of Reproductive Immunology 68(4): 338-344.
11. Shinkai, A., et al. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. Journal of Immunology 163(3): 1602-1610.
12. Ahmadi, Z., M.K. Arababadi, and G. Hassanshahi. 2012. CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus. Inflammation. doi: 10.1007/s10753-012-9555-1.
13. Kitaura, M., et al. 1999. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 274(39): 27975-27980.
14. Ponath, P.D., et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. Journal of Experimental Medicine 183(6): 2437-2448.
15. Uguccioni, M., et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. Journal of Clinical Investigation 100(5): 1137-1143.
16. Plager, D.A., et al. 2010. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 5(7): e11450.
17. Clark, A.T., and P.W. Ewan. 2004. Food allergy in childhood. Archives of Disease in Childhood 89(2): 197.
18. Simons, F.E. 2010. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings. Annals of Allergy, Asthma & Immunology 104(5): 405-412.
19. Blazquez, A.B., et al. 2010. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology 138(1): 275-284. e1-4. Epub 2009 Sep 23.
20. Lamkhioued, B., et al. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Journal of Immunology 159(9): 4593-4601.
21. Yamada, H., et al. 2000. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55(4): 392-397.
22. Taha, R.A., et al. 2001. Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120(2): 595-601.
23. Bottcher, M.F., et al. 2000. Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatric Research 47(5): 592-597.
24. Taha, R.A., et al. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Journal of Allergy and Clinical Immunology 105(5): 1002-1007.
25. Li, H., et al. 2007. Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology 133(6): 1905-1915. Epub 2007 Sep 25.
26. Hakimizadeh, E., et al. 2012. Association of -592 region of IL-10 polymorphisms with asthma in south-eastern Iranian patients. Clinical Laboratory 58(3-4): 267-271.
27. Berkman, N., et al. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 h after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 24(6): 682-687.
28. Kagami, S., et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clinical and Experimental Immunology 134(2): 309-313.
29. Polzer, K., et al. 2008. Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity. Rheumatology (Oxford, England) 47(6): 804-808. Epub 2008 Apr 8.
30. Fulkerson, P.C., et al. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proceedings of the National Academy of Sciences of the United States of America 103(44): 16418-16423. Epub 2006 Oct 23.
31. Matsuura, H., et al. 2009. Elevation of plasma eotaxin levels in children with food allergy. Nihon Rinshō Men'eki Gakkai Kaishi 32(3): 180-185.
32. Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunology Today 15(3): 127-133.
33. Lukacs, N.W. 2001. Role of chemokines in the pathogenesis of asthma. Nature Reviews Immunology 1(2): 108-116.
34. Kaplan, A.P. 2001. Chemokines, chemokine receptors and allergy. International Archives of Allergy and Immunology 124(4): 423-431.